Sokol ES - Search Results

1

Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency Signature.

Batalini F, Madison RW, Sokol ES, Jin DX, Chen KT, Decker B, Pavlick DC, Frampton GM, Wulf GM, Garber JE, Oxnard G, Schrock AB, Tung NM. Batalini F, et al. Among authors: sokol es. JCO Precis Oncol. 2023 Sep;7:e2300091. doi: 10.1200/PO.23.00091. JCO Precis Oncol. 2023. PMID: 37992259 Free PMC article.

2

Suppression of 19S proteasome subunits marks emergence of an altered cell state in diverse cancers.

Tsvetkov P, Sokol E, Jin D, Brune Z, Thiru P, Ghandi M, Garraway LA, Gupta PB, Santagata S, Whitesell L, Lindquist S. Tsvetkov P, et al. Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):382-387. doi: 10.1073/pnas.1619067114. Epub 2016 Dec 27. Proc Natl Acad Sci U S A. 2017. PMID: 28028240 Free PMC article.

3

Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1.

Feng YX, Jin DX, Sokol ES, Reinhardt F, Miller DH, Gupta PB. Feng YX, et al. Among authors: sokol es. Nat Commun. 2017 Oct 20;8(1):1079. doi: 10.1038/s41467-017-01052-y. Nat Commun. 2017. PMID: 29057869 Free PMC article.

4

BCL11B Drives Human Mammary Stem Cell Self-Renewal In Vitro by Inhibiting Basal Differentiation.

Miller DH, Jin DX, Sokol ES, Cabrera JR, Superville DA, Gorelov RA, Kuperwasser C, Gupta PB. Miller DH, et al. Among authors: sokol es. Stem Cell Reports. 2018 Mar 13;10(3):1131-1145. doi: 10.1016/j.stemcr.2018.01.036. Epub 2018 Mar 1. Stem Cell Reports. 2018. PMID: 29503088 Free PMC article.

5

Unusually long-term responses to vemurafenib in BRAF V600E mutated colon and thyroid cancers followed by the development of rare RAS activating mutations.

Ofir Dovrat T, Sokol E, Frampton G, Shachar E, Pelles S, Geva R, Wolf I. Ofir Dovrat T, et al. Cancer Biol Ther. 2018;19(10):871-874. doi: 10.1080/15384047.2018.1480289. Epub 2018 Jul 23. Cancer Biol Ther. 2018. PMID: 30036146 Free PMC article.

6

Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer.

Sokol ES, Feng YX, Jin DX, Basudan A, Lee AV, Atkinson JM, Chen J, Stephens PJ, Frampton GM, Gupta PB, Ross JS, Chung JH, Oesterreich S, Ali SM, Hartmaier RJ. Sokol ES, et al. Ann Oncol. 2019 Jan 1;30(1):115-123. doi: 10.1093/annonc/mdy497. Ann Oncol. 2019. PMID: 30423024 Free PMC article.

7

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.

Schrock AB, Ouyang C, Sandhu J, Sokol E, Jin D, Ross JS, Miller VA, Lim D, Amanam I, Chao J, Catenacci D, Cho M, Braiteh F, Klempner SJ, Ali SM, Fakih M. Schrock AB, et al. Ann Oncol. 2019 Jul 1;30(7):1096-1103. doi: 10.1093/annonc/mdz134. Ann Oncol. 2019. PMID: 31038663 Free article.

8

Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors.

Chung JH, Dewal N, Sokol E, Mathew P, Whitehead R, Millis SZ, Frampton GM, Bratslavsky G, Pal SK, Lee RJ, Necchi A, Gregg JP, Lara P Jr, Antonarakis ES, Miller VA, Ross JS, Ali SM, Agarwal N. Chung JH, et al. Among authors: sokol e. JCO Precis Oncol. 2019;3:PO.18.00283. doi: 10.1200/PO.18.00283. Epub 2019 May 10. JCO Precis Oncol. 2019. PMID: 31218271 Free PMC article.

9

Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer.

Chae YK, Viveiros P, Lopes G, Sukhadia B, Sheikh MM, Saravia D, Florou V, Sokol ES, Frampton GM, Chalmers ZR, Ali SM, Ross JS, Chang S, Wang S, Chiec L, Rahbari A, Mohindra N, Villaflor V, Shin SH, Oh M, Anker J, Park LC, Wang V, Chuang J, Park W. Chae YK, et al. Among authors: sokol es. J Thorac Oncol. 2019 Oct;14(10):1807-1817. doi: 10.1016/j.jtho.2019.06.016. Epub 2019 Jun 22. J Thorac Oncol. 2019. PMID: 31238177 Free article.

10

Pan-Cancer Analysis of CDK12 Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator Phenotype.

Sokol ES, Pavlick D, Frampton GM, Ross JS, Miller VA, Ali SM, Lotan TL, Pardoll DM, Chung JH, Antonarakis ES. Sokol ES, et al. Oncologist. 2019 Dec;24(12):1526-1533. doi: 10.1634/theoncologist.2019-0214. Epub 2019 Jul 10. Oncologist. 2019. PMID: 31292271 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

112 results

Search Page